BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19144510)

  • 1. C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation.
    De Mattia E; Toffoli G
    Eur J Cancer; 2009 May; 45(8):1333-51. PubMed ID: 19144510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
    Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
    Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer.
    Zhang W; Press OA; Haiman CA; Yang DY; Gordon MA; Fazzone W; El-Khoueiry A; Iqbal S; Sherrod AE; Lurje G; Lenz HJ
    J Clin Oncol; 2007 Aug; 25(24):3726-31. PubMed ID: 17704422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia.
    Eissa DS; Ahmed TM
    Blood Coagul Fibrinolysis; 2013 Mar; 24(2):181-8. PubMed ID: 23183238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
    Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma.
    Kono S; Chen K
    Cancer Sci; 2005 Sep; 96(9):535-42. PubMed ID: 16128738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
    Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
    Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation.
    Terrazzino S; Agostini M; Pucciarelli S; Pasetto LM; Friso ML; Ambrosi A; Lisi V; Leon A; Lise M; Nitti D
    Pharmacogenet Genomics; 2006 Nov; 16(11):817-24. PubMed ID: 17047490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis.
    Schmeling H; Biber D; Heins S; Horneff G
    J Rheumatol; 2005 Sep; 32(9):1832-6. PubMed ID: 16142884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic relevance of MTHFR polymorphisms.
    Toffoli G; De Mattia E
    Pharmacogenomics; 2008 Sep; 9(9):1195-206. PubMed ID: 18781847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients.
    Sakano S; Hinoda Y; Okayama N; Kawai Y; Ito H; Nagao K; Hara T; Matsuyama H
    BJU Int; 2010 Aug; 106(3):424-30. PubMed ID: 20039875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cystathionine beta-synthase variant 844ins68bp and methylenetetrahydrofolate reductase A1298C polymorphisms in xenografts on 5-FU efficacy and doubling time.
    Sasaki S; Watanabe T; Kobunai T; Nagawa H
    Cancer Lett; 2006 Sep; 241(2):256-62. PubMed ID: 16307843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.
    D'Angelo V; Ramaglia M; Iannotta A; Crisci S; Indolfi P; Francese M; Affinita MC; Pecoraro G; Napolitano A; Fusco C; Oreste M; Indolfi C; Casale F
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1339-46. PubMed ID: 21590445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review.
    Gilbody S; Lewis S; Lightfoot T
    Am J Epidemiol; 2007 Jan; 165(1):1-13. PubMed ID: 17074966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequencies of C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene at the early stage of human individual development].
    Nazarenko MS; Puzyrev VP; Lebedev IN
    Genetika; 2006 May; 42(5):711-7. PubMed ID: 16808252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review.
    Boccia S; Hung R; Ricciardi G; Gianfagna F; Ebert MP; Fang JY; Gao CM; Götze T; Graziano F; Lacasaña-Navarro M; Lin D; López-Carrillo L; Qiao YL; Shen H; Stolzenberg-Solomon R; Takezaki T; Weng YR; Zhang FF; van Duijn CM; Boffetta P; Taioli E
    Am J Epidemiol; 2008 Mar; 167(5):505-16. PubMed ID: 18162478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The common MTHFR C677T and A1298C variants are not associated with the risk of non-syndromic cleft lip/palate in northern Venezuela.
    Sözen MA; Tolarova MM; Spritz RA
    J Genet Genomics; 2009 May; 36(5):283-8. PubMed ID: 19447376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer.
    Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ
    Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure to confirm influence of methyltetrahydrofolate reductase (MTHFR) polymorphisms on age at onset of Huntington disease.
    Hansen W; Saft C; Andrich J; Müller T; Wieczorek S; Epplen JT; Arning L
    J Negat Results Biomed; 2005 Dec; 4():12. PubMed ID: 16372906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.